Reuters -- Swiss drugmaker Novartis AG has bought privately held U.S. company Oriel Therapeutics to boost its generics portfolio in the multibillion-dollar market for respiratory drugs.
Reuters -- Swiss drugmaker Novartis AG has bought privately held U.S. company Oriel Therapeutics to boost its generics portfolio in the multibillion-dollar market for respiratory drugs.